Our ESG team has a robust understanding of the regulatory and policy drivers of the market and experience across a wide range of sectors and contexts.
3 December 2024
Linklaters has advised global investment firm Carlyle Global Credit on its strategic capital investment in Orifarm Group A/S, a family-owned, international healthcare company which supplies high quality pharmaceuticals at affordable prices across three business lines: Pharma Trade, Specialty Rx and Consumer Healthcare.
2 December 2024
Linklaters has launched an AI Sandbox which will allow the firm to quickly build out AI solutions, many of which have stemmed from ideas suggested by its people. Ideas will be brought to life through tailored solutions in the firm’s homegrown chatbot Laila, or in partnership with external vendors.
2 December 2024
Linklaters has advised the underwriters on the initial public offering (IPO) of Talabat Holding PLC and its listing in the UAE on the Dubai Financial Market (“DFM”), raising US$2 billion in the largest global tech IPO in 2024 to date.
29 November 2024
Linklaters has taken over as co-chair of Legal CORE (Collaboration on Race and Ethnicity), a leadership-led, cross-firm collective aimed at tackling the underrepresentation of minority ethnic groups in the UK legal sector, alongside Clifford Chance.
27 November 2024
Linklaters has advised The Bank of New York Mellon Corporation (BNY) as custodian and paying agent on the European Investment Bank (EIB)’s sixth digital bond issuance, and the second EIB issuance in the context of the Eurosystem exploratory work on new technologies for wholesale central bank money settlement (ECB trials).
25 November 2024
Linklaters had advised Onex Partners on the debt financing of Onex’ investment in Fischbach KG.